Business ❯ Pharmaceutical Industry ❯ Market Competition

Drug Approval

Novo Nordisk Eli Lilly Johnson & Johnson Health Insurance Clinical Trials FDA Regulations Investor Insights Investment Opportunities Regulatory Authorities

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

European Commission approval would create the first oral GLP‑1 for adult weight management with pricing left to EU Member States.

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla